Prognostic value of a modified systemic inflammation score in breast cancer patients who underwent neoadjuvant chemotherapy

BACKGROUND AND PURPOSE: The modified systemic inflammation score (mSIS) system, which is constructed based on the neutrophil to lymphocyte ratio (NLR) and albumin (Alb), has not been applied to evaluate the prognosis of malignant breast cancer patients who underwent neoadjuvant chemotherapy (NAC). T...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Cong, Xiu, Yuting, Yu, Xiao, Qiao, Kun, Zhang, Shiyuan, Huang, Yuanxi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9717545/
https://www.ncbi.nlm.nih.gov/pubmed/36460981
http://dx.doi.org/10.1186/s12885-022-10291-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9717545/
https://www.ncbi.nlm.nih.gov/pubmed/36460981
http://dx.doi.org/10.1186/s12885-022-10291-2

Ejemplares similares